期刊文献+

Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma:Application to a pharmacokinetic study 被引量:4

Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma:Application to a pharmacokinetic study
下载PDF
导出
摘要 A reliable,selective and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the quantification of lamotrigine in human plasma using lamotrigine13C3,d3 as an internal standard.Analyte and internal standard were extracted from human plasma by solid-phase extraction and detected in positive ion mode by tandem mass spectrometry with electrospray ionization(ESI) interface.Chromatographic separation was performed on a Chromolith s SpeedROD;RP-18e column(50-4.6 mm i.d.) using acetonitrile:570.1 mM ammonium formate solution(90:10,v/v) as the mobile phase at a flow rate of 0.500 mL/min.The calibration curves were linear over the range of 5.02-1226.47 ng/mL with the lower limit of quantitation validated at 5.02 ng/mL.The analytes were found stable in human plasma through three freeze(-20℃)-thaw(ice-cold water bath) cycles and under storage on bench-top in ice-cold water bath for at least 6.8 h,and also in the mobile phase at 10℃ for at least 57h.The method has shown good reproducibility,as the intra-and inter-day precisions were within 3.0%,while the accuracies were within 76.0% of nominal values.The validated LC-MS/MS method was applied for the evaluation of pharmacokinetic and bioequivalence parameters of lamotrigine after an oral administration of 50mg lamotrigine tablet to thirty-two healthy adult male volunteers. A reliable,selective and sensitive liquid chromatography tandem mass spectrometry method was developed and validated for the quantification of lamotrigine in human plasma using lamotrigine13C3,d3 as an internal standard.Analyte and internal standard were extracted from human plasma by solid-phase extraction and detected in positive ion mode by tandem mass spectrometry with electrospray ionization(ESI) interface.Chromatographic separation was performed on a Chromolith s SpeedROD;RP-18e column(50-4.6 mm i.d.) using acetonitrile:570.1 mM ammonium formate solution(90:10,v/v) as the mobile phase at a flow rate of 0.500 mL/min.The calibration curves were linear over the range of 5.02-1226.47 ng/mL with the lower limit of quantitation validated at 5.02 ng/mL.The analytes were found stable in human plasma through three freeze(-20℃)-thaw(ice-cold water bath) cycles and under storage on bench-top in ice-cold water bath for at least 6.8 h,and also in the mobile phase at 10℃ for at least 57h.The method has shown good reproducibility,as the intra-and inter-day precisions were within 3.0%,while the accuracies were within 76.0% of nominal values.The validated LC-MS/MS method was applied for the evaluation of pharmacokinetic and bioequivalence parameters of lamotrigine after an oral administration of 50mg lamotrigine tablet to thirty-two healthy adult male volunteers.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2013年第2期75-83,共9页 药物分析学报(英文版)
关键词 Lamotrigine Liquid chromatography/tandem mass spectrometry Solid phase extraction Pharmacokinetic study Lamotrigine Liquid chromatography/tandem mass spectrometry Solid phase extraction Pharmacokinetic study
  • 相关文献

参考文献29

  • 1A.A. Miller, P. Wheatley, D.A. Sawyer, et al., Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats, Epilepsia 27 (1986) 483-489.
  • 2A.F. Cohen, G.S. Land, D.D. Breimer, et al., Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans, Clin. Phar- macol. Ther. 42 (1987) 535-541.
  • 3R.A. Biddlecombe, K.L. Dean, C.D. Smith, et al., Validation of a radioimmunoassay for the determination of human plasma concentrations of lamotrigine, J. Pharm. Biomed. Anal. 8 (1990) 691 694.
  • 4M.W. Sinz, R.P. Remmel, Analysis of lamotrigine and lamotri- gine 2-N-glucuronide in guinea pig blood and urine by reserved- phase ion-pairing liquid chromatography, J. Chromatogr. 571 (1991) 217330.
  • 5S. Yamashita, K. Furuno, H. Kawasaki, et al., Simple and rapid analysis of lamotrigine, a novel antiepileptic, in human serum by high-performance liquid chromatography using a solid-phase extraction technique, J. Chromatogr. B 670 (1995) 354357.
  • 6B.C. Sallustio, R.'G. Morris, High-performance liquid chromato- graphy quantitation of plasma lamotrigine concentrations: appli- cation measuring trough concentrations in patients with epilepsy, Ther. Drug Monit. 19 (1997) 688-693.
  • 7G.L. Lensmeyer, B.E. Gidal, D.A. Wiebe, Optimized high- performance liquid chromatographic method for determinationof lamotrigine in serum with concomitant determination of phenytoin, carbamazepine, and carbamazepine epoxide, Ther. Drug Monit. 19 (1997) 292-300.
  • 8[ A. Bartoli, R. Marchiselli, G. Gatti, A rapid and specific assay for the determination of lamotrigine in human plasma by normal- phase HPLC, Ther. Drug Monit. 19 (1997) 100-107.
  • 9D. Londero, P.L. Greco, New micromethod for the determina- tion of lamotrigine in human plasma by high-performance liquid chromatography, J. Chromatogr. B 691 (1997) 139-144.
  • 10K.M. Matar, P.J. Nicholls, S.A. Bawazir, et al., A rapid liquid chromatographic method for the determination of lamotrigine in plasma, J. Pharm. Biomed. Anal. 17 (1998) 525-531.

同被引文献16

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部